PureTech Health plc
A clinical-stage biotherapeutics company developing new medicines for devastating diseases.
PRTC | IL
Overview
Corporate Details
- ISIN(s):
- GB00BPVG5C82 (+2 more)
- LEI:
- 213800LVPDNO2Z9T9I39
- Country:
- United States of America
- Address:
- 6 TIDE STREET, 2210 BOSTON
- Website:
- https://puretechhealth.com/
- Sector:
- Manufacturing
Description
PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-12-11 18:30 |
Holding(s) in Company
|
English | 23.9 KB | ||
| 2024-12-11 13:05 |
PRTC's Seaport Presents Ph1 SPT-300 Data at ACNP
|
English | 17.9 KB | ||
| 2024-12-09 08:00 |
PRTC Presents LYT-200 Phase 1b Data in AML at ASH
|
English | 20.3 KB | ||
| 2024-11-27 18:31 |
Holding(s) in Company
|
English | 24.2 KB | ||
| 2024-11-27 18:30 |
Holding(s) in Company
|
English | 23.9 KB | ||
| 2024-11-20 13:05 |
PRTC's Seaport Adds Microsoft and J&J Exec to BOD
|
English | 16.7 KB | ||
| 2024-11-05 13:05 |
PRTC's Seaport Adds Biotech Finance Exec as CFO
|
English | 16.2 KB | ||
| 2024-11-01 08:00 |
Total Voting Rights
|
English | 9.6 KB | ||
| 2024-10-31 18:00 |
Director/PDMR Shareholding
|
English | 18.7 KB | ||
| 2024-10-30 12:00 |
PRTC to Present at UBS and Jefferies Conferences
|
English | 10.1 KB | ||
| 2024-10-21 08:00 |
PRTC's Seaport Closes $225M Series B Financing
|
English | 26.9 KB | ||
| 2024-10-09 08:00 |
PRTC's IPF Patient Research & Ph 2b On Track YE24
|
English | 21.5 KB | ||
| 2024-10-01 13:00 |
PRTC to Give 3 Presentations at CHEST 2024 Meeting
|
English | 18.6 KB | ||
| 2024-09-27 08:00 |
KarXT/Cobenfy Approved by FDA; PRTC Receives $29M
|
English | 28.8 KB | ||
| 2024-09-06 19:13 |
Holding(s) in Company
|
English | 25.2 KB |
Automate Your Workflow. Get a real-time feed of all PureTech Health plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PureTech Health plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PureTech Health plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
